Robert Galamaga
Overview
Explore the profile of Robert Galamaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avatrombopag for the treatment of patients with chemotherapy-induced thrombocytopenia: A case series
Galamaga R, Johnston S, Acosta C
Br J Haematol
. 2024 Oct;
206(1):272-278.
PMID: 39434457
Management of chemotherapy-induced thrombocytopenia (CIT) is challenging, often resulting in chemotherapy treatment delays, dose reduction, and treatment interruption. Randomized trials support the potential efficacy and safety of thrombopoietin receptor agonists...
2.
Trinh J, Acosta C, Easwar A, Galamaga R, Tan A
Cancer Rep (Hoboken)
. 2023 Oct;
7(1):e1915.
PMID: 37867289
Background: Sinonasal undifferentiated carcinoma (SNUC) is an exceedingly rare head and neck malignancy. No consensus exists on treatment for metastatic disease. Case: A 56-year-old female was diagnosed with SNUC after...
3.
Vogelzang N, Olsen M, McFarlane J, Arrowsmith E, Bauer T, Jain R, et al.
Clin Genitourin Cancer
. 2020 Jul;
18(6):461-468.e3.
PMID: 32718906
Background: The open-label phase IIIb/IV CheckMate 374 study (NCT02596035) was conducted to validate the safety and efficacy of flat-dose nivolumab 240 mg every 2 weeks (Q2W) in previously treated advanced/metastatic...
4.
Petrich A, Helenowski I, Bryan L, Rozell S, Galamaga R, Nabhan C
Br J Haematol
. 2014 Nov;
168(5):708-18.
PMID: 25382108
Current prognostic models for peripheral T-cell lymphoma (PTCL) have multiple limitations, and questions exist regarding applicability to current patients. We utilized the Surveillance Epidemiology and End Results (SEER)-18 database to...